KHTRF
Price
$4.63
Change
-$0.06 (-1.28%)
Updated
Sep 4 closing price
Capitalization
464.5M
MEDXF
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
71.91M
58 days until earnings call
Interact to see
Advertisement

KHTRF vs MEDXF

Header iconKHTRF vs MEDXF Comparison
Open Charts KHTRF vs MEDXFBanner chart's image
Knight Therapeutics
Price$4.63
Change-$0.06 (-1.28%)
Volume$11.6K
Capitalization464.5M
Medexus Pharmaceuticals
Price$2.20
Change-$0.00 (-0.00%)
Volume$1K
Capitalization71.91M
KHTRF vs MEDXF Comparison Chart in %
Loading...
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KHTRF vs. MEDXF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KHTRF is a Hold and MEDXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (KHTRF: $4.63 vs. MEDXF: $2.20)
Brand notoriety: KHTRF and MEDXF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KHTRF: 528% vs. MEDXF: 8%
Market capitalization -- KHTRF: $464.5M vs. MEDXF: $71.91M
KHTRF [@Pharmaceuticals: Generic] is valued at $464.5M. MEDXF’s [@Pharmaceuticals: Generic] market capitalization is $71.91M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KHTRF’s FA Score shows that 0 FA rating(s) are green whileMEDXF’s FA Score has 1 green FA rating(s).

  • KHTRF’s FA Score: 0 green, 5 red.
  • MEDXF’s FA Score: 1 green, 4 red.
According to our system of comparison, MEDXF is a better buy in the long-term than KHTRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KHTRF’s TA Score shows that 2 TA indicator(s) are bullish while MEDXF’s TA Score has 5 bullish TA indicator(s).

  • KHTRF’s TA Score: 2 bullish, 5 bearish.
  • MEDXF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MEDXF is a better buy in the short-term than KHTRF.

Price Growth

KHTRF (@Pharmaceuticals: Generic) experienced а -1.91% price change this week, while MEDXF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.11%.

Reported Earning Dates

MEDXF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KHTRF($464M) has a higher market cap than MEDXF($71.9M). MEDXF has higher P/E ratio than KHTRF: MEDXF (110.00) vs KHTRF (62.66). KHTRF YTD gains are higher at: 28.255 vs. MEDXF (-8.903). KHTRF has higher annual earnings (EBITDA): 52M vs. MEDXF (17.8M). KHTRF has more cash in the bank: 116M vs. MEDXF (8.44M). MEDXF has less debt than KHTRF: MEDXF (39.9M) vs KHTRF (105M). KHTRF has higher revenues than MEDXF: KHTRF (385M) vs MEDXF (110M).
KHTRFMEDXFKHTRF / MEDXF
Capitalization464M71.9M645%
EBITDA52M17.8M292%
Gain YTD28.255-8.903-317%
P/E Ratio62.66110.0057%
Revenue385M110M350%
Total Cash116M8.44M1,374%
Total Debt105M39.9M263%
FUNDAMENTALS RATINGS
KHTRF vs MEDXF: Fundamental Ratings
KHTRF
MEDXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9267
PRICE GROWTH RATING
1..100
5148
P/E GROWTH RATING
1..100
979
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KHTRF's Valuation (72) in the null industry is in the same range as MEDXF (82). This means that KHTRF’s stock grew similarly to MEDXF’s over the last 12 months.

KHTRF's Profit vs Risk Rating (100) in the null industry is in the same range as MEDXF (100). This means that KHTRF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's SMR Rating (67) in the null industry is in the same range as KHTRF (92). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

MEDXF's Price Growth Rating (48) in the null industry is in the same range as KHTRF (51). This means that MEDXF’s stock grew similarly to KHTRF’s over the last 12 months.

MEDXF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for KHTRF (97). This means that MEDXF’s stock grew significantly faster than KHTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KHTRFMEDXF
RSI
ODDS (%)
Bearish Trend 4 days ago
45%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
46%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
36%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
33%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
35%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
41%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
37%
Bearish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
KHTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGKZX29.830.26
+0.88%
PGIM Jennison Technology Z
FEBRX15.090.05
+0.33%
First Eagle Global Income Builder R6
SRUIX15.09-0.03
-0.20%
Meeder Spectrum Institutional
PPUPX16.34-0.04
-0.24%
Principal LargeCap Growth I R5
RGERX21.36-0.08
-0.37%
Columbia Select Global Equity Inst2

KHTRF and

Correlation & Price change

A.I.dvisor tells us that KHTRF and ESALF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KHTRF and ESALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KHTRF
1D Price
Change %
KHTRF100%
N/A
ESALF - KHTRF
27%
Poorly correlated
+0.06%
OVATF - KHTRF
25%
Poorly correlated
N/A
TAK - KHTRF
22%
Poorly correlated
+0.72%
JUSHF - KHTRF
13%
Poorly correlated
+6.59%
HYPMY - KHTRF
8%
Poorly correlated
+1.57%
More

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
N/A
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
-8.53%
MKGAF - MEDXF
7%
Poorly correlated
+1.49%
KHTRF - MEDXF
5%
Poorly correlated
N/A
MCUJF - MEDXF
4%
Poorly correlated
N/A
More